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Synopsis:

Alzheimer’s disease (AD) is the most common cause of elderly dementia, which is characterized by presence of neurofibrillary tangles and senile plaques in the brain. The disease primarily affects regions of the brain responsible for memory and thought processes. Till date no satisfactory diagnostic marker or drug is available for the disease. In most of the cases, the precise aetiology is not known, nevertheless some genetic alterations have been found to be associated with early onset of the disease symptoms in some families. These genetic alterations are related with abnormal metabolism and deposition of a peptide known as amyloid beta (Aβ). These peptides may be present in both intracellular compartments and the extracellular milieu. 
Present study was carried out to evaluate the effects of Aβ on the hippocampus, one of the most severely affected areas in the AD brain. In the first part of our study, we have demonstrated that intra-hippocampal injected Aβ remained in the hippocampus for at least 30 days study period and caused a considerable damage in the dentate gyrus near injection site and induce impairment in performance in passive avoidance test.
Histologically, neurons of granular layer of the DG were severely damaged. Interestingly, despite of robust microgliosis in the stratum lucidum layer of CA3 and CA4, the adjacent pyramidal cells were not affected. This implies the possibility of disruption of functions of CA3 neurons and disruption of mossy neurotransmission with DG and perforant connections with entorhinal cortex. Therefore, it can be proposed that Aβ induced behavioural defects in our model could be due to progressive disruption in synaptic network of the hippocampus.  Proteomic profiling of the Aβ injected hippocampus shows that many proteins involved in differentiation of new neurons and maintenance of neuronal polarity such as nestin, shootin-1 and neuroligin-1 were notably down-regulated.  Proteins functionally related to energy metabolism and signal transduction were also affected. 
As this model does not have intra-neuronal Aβ, we opted for endogenously Aβ expressing animal model, APdE9 mice in the second part of the study. Our study showed that neurotransmitter specific dystrophies were only restricted to areas adjacent to the plaques. These peri-plaque areas are occupied by robust accumulation of microglial cells. These observations show that a microglia dependent inflammation is probably contributing to the localised dystrophy near the plaques. Therefore, it seems that Aβ induces localised effects in the brain and may require a long period of time to induce comprehensive influence on the systemic network.
As the mitochondrial dysfunction has been reported in dystrophic neurites of AD, we hypothesised that Aβ may interact with mitochondrial proteins and contribute to the dysfunction in energy homeostasis at the synaptic terminals. Therefore as a preliminary step, we attempted to see the in silico interaction of Aβ with mitochondrial proteins and found that Aβ may interact with adenine nucleotidyl translocase and obstruct transport of ADP/ATP. 
In conclusion, it can be suggested that effects of exogenously injected aggregated Aβ are possibly due to progressive loss of hippocampal network. Similarly, effects of the endogenously expressed Aβ are also mostly dependent on extracellular depositions and progressive disruption of synaptic network in the plaque bearing regions of the brain. Intracellular Aβ may facilitate the plaque associated damage at the neuronal terminals. Therefore, this model is also conveying same message that Aβ deposition causes progressive disruption in brain network and later on, cognitive decline. Our study suggests that injection of aggregated Aβ into the hippocampus of rats provides an efficient and cost effective model for understanding of disease progression. 


